Landmark approval for Dendreon's cancer vaccine.
Laura
L
DeFrancesco
D000368:Aged; D019496:Cancer Vaccines / Q000191:economics / Q000276:immunology; D002986:Clinical Trials as Topic; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D007167:Immunotherapy; D008297:Male; D011471:Prostatic Neoplasms / Q000276:immunology / Q000628:therapy; D016019:Survival Analysis; D014020:Tissue Extracts / Q000191:economics / Q000276:immunology; D014481:United States; D014486:United States Food and Drug Administration
D019496:Cancer Vaccines; D014020:Tissue Extracts; C511774:sipuleucel-T